Clinical Trial Update: Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating MenACYW Conjugate Vaccine co-administered with routine pediatric vaccines in healthy infants and toddlers in India and the Republic of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• MenACYW Conjugate Vaccine (MenACWY conjugate vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningococcal Immunisation, Healthy Volunteers | Phase 3 | Status: COMPLETED